BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells
about
sameAs
NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradationDcas supports cell polarization and cell-cell adhesion complexes in developmentCas proteins: dodgy scaffolding in breast cancerBreast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathwayPulmonary proteome and protein networks in response to the herbicide paraquat in ratsThe docking protein HEF1 is an apoptotic mediator at focal adhesion sitesCAS proteins in normal and pathological cell growth controlA novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphologyNSP-Cas protein structures reveal a promiscuous interaction module in cell signalingProtein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrateThe serine-rich domain from Crk-associated substrate (p130cas) is a four-helix bundleProtein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesA novel Cas family member, HEPL, regulates FAK and cell spreading.Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomicsCas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.NSP-CAS Protein Complexes: Emerging Signaling Modules in CancerHEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networksAssociation of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistanceLoss of AND-34/BCAR3 expression in mice results in rupture of the adult lensBreast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas)Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasivenessThe SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein CasDynamics and mechanism of p130Cas localization to focal adhesionsRegulation of focal adhesion and cell migration by ANKRD28-DOCK180 interactionThe v-Crk oncogene enhances cell survival and induces activation of protein kinase B/Akt.Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane rufflingBCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signalingCrosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.Pathways to tamoxifen resistance.Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and SrcSRChing for the substrates of Src.Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer.BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancerDecreased expression of EFS is correlated with the advanced prostate cancer.Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edgeKinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
P2860
Q21135305-275E4C3E-45A4-4270-9329-87513600E120Q21136167-E9BBD66F-1199-4923-A688-15E4587AB9D1Q21146639-E314F0A3-4481-49FB-B6E5-7581818D64D6Q21195156-6831FC0C-6E9E-4050-88A2-AAD8183D7A3AQ23913727-9E68B9D6-A537-4E07-9A9C-B724F72A57FEQ24553123-1EBDE155-CC45-4C05-8138-D4F1B986810DQ24630247-38E81E42-9BC9-43B3-8138-02623E5833AAQ24648671-B1A6FF3D-0865-4DB0-9D3E-27983B73379AQ24654076-F72DC843-7936-46C1-BEC3-99EC66F48D99Q27675552-86ADC649-0C84-4FA5-9F0F-E705B55B8236Q28115210-9FB8C541-11CC-4B54-8FA3-3B9AAD33DABCQ28242010-6B8BB0BC-51B2-4A5B-8664-6AEDDE0E393AQ28259553-9DBD383C-7BF5-4CA2-9FC2-73BD1E4F589EQ28267647-5FE472F1-F1BE-4170-AB20-C3A6F569132AQ28277407-593B28F3-0E2D-487B-92DC-F28C3D6E4B8AQ28281154-C6F750C1-D257-4573-980E-C109C942A30BQ28281166-CEA54F19-02A4-4582-AE5F-9C74E6F05D51Q28297459-FCB82F83-7AFB-426A-9283-08F464226EB7Q28308160-37587B0C-86B3-4573-B770-782B0AAE1E30Q28510147-59424231-56E5-499A-BD7E-7524D95F4016Q30010068-599A4F67-AE1F-4723-BF9A-102D7B5920B6Q30010235-A4B105A7-EDF3-49AB-A65B-9894EC1C3FDEQ30156800-677DE9D9-DDEF-4FD4-A5D2-3DC074B0A364Q30156887-F8E33BE6-81EC-41D2-A97A-4314D5A9C9F8Q30157247-98DA7A28-9E1A-4120-A967-C9374D690016Q30168223-CEDF3A59-2DF0-4196-B09B-5E9661274BF4Q30372977-7CCADB93-931B-4FAE-B793-03D53FFEB16DQ30411760-804D0E21-FCA7-4E5F-A907-BB45B9AB45BCQ30433442-5877F2BE-ECCF-4153-AFE1-FAABF417E28BQ30434843-F7BC7D7F-1139-4248-B6ED-141D5083CF4BQ30439082-52F5F391-1D3B-4280-8E49-0BBD19A0C944Q30441001-A2416E83-A995-42B2-9B8A-E8626C9CFBA4Q30453539-47CF63D4-53D9-4EDD-8A8B-1D393DE9BA59Q30457060-452B5509-ABCE-47D1-812C-B6275E2A5C7FQ33567579-1E72EB39-6CE7-49F8-B8BF-A00D4586B62BQ34255976-0F0F5FD7-C794-4C46-A2B9-049D9203D775Q34257178-E6AA17E5-69EA-4826-8830-54727C6CB8D3Q34442484-EB520676-B569-46D6-9F4A-BC0BF5281A6BQ34661735-0E18F089-7D0D-4A7D-B833-A6542DE44EC1Q34979448-C9045496-9B6A-4DC9-8B25-FA11D9E1D535
P2860
BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
BCAR1, a human homologue of th ...... istance in breast cancer cells
@ast
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en-gb
BCAR1, a human homologue of th ...... istance in breast cancer cells
@nl
type
label
BCAR1, a human homologue of th ...... istance in breast cancer cells
@ast
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en-gb
BCAR1, a human homologue of th ...... istance in breast cancer cells
@nl
prefLabel
BCAR1, a human homologue of th ...... istance in breast cancer cells
@ast
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en-gb
BCAR1, a human homologue of th ...... istance in breast cancer cells
@nl
P2093
P2860
P356
P1476
BCAR1, a human homologue of th ...... istance in breast cancer cells
@en
P2093
A Brinkman
L C Dorssers
S van der Flier
P2860
P304
P356
10.1093/JNCI/92.2.112
P407
P577
2000-01-19T00:00:00Z